Option Care Health, Inc. (NASDAQ:OPCH) Holdings Cut by Vontobel Holding Ltd.

Vontobel Holding Ltd. lowered its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 10,490 shares of the company’s stock after selling 488 shares during the period. Vontobel Holding Ltd.’s holdings in Option Care Health were worth $243,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Wellington Management Group LLP increased its stake in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after purchasing an additional 1,328,326 shares during the period. FMR LLC increased its stake in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after purchasing an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP increased its stake in shares of Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares during the period. State Street Corp increased its stake in shares of Option Care Health by 1.4% in the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after purchasing an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans increased its stake in shares of Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after purchasing an additional 404,811 shares during the period. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 1.2 %

Option Care Health stock opened at $32.00 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $5.45 billion, a price-to-earnings ratio of 26.89, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63. The firm’s 50 day moving average price is $27.71 and its two-hundred day moving average price is $27.99.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on OPCH. JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Finally, Truist Financial lowered their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.